Partnership creates the largest oncology research network in the United States, enabling clinical trials to reach rural and community-based practices COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 ...
The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes of Health (NIH). A new analysis reveals that the termination of NIH grants ...
n = 345 adults seeking web based ADHD assessment (predominantly female; mean age = 35). Sensitivity = 80.6% and Positive Predictive Value = 94.9%. False positive rate = 12% versus 56% for the clinical ...
Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...
A pair of CROs from opposite sides of the Atlantic Ocean are merging to form a global organization. Evestia Clinical and Atlantic Research Group are joining forces to bring clients expertise in ...
Merriam, Kansas-based Advent Health Shawnee Mission Hospital has filed a lawsuit against Blue Cross and Blue Shield of Kansas City for artificial intelligence-driven technology that the provider said ...
Background: Chronic atrophic gastritis (CAG), an early stage of gastric cancer, is a major digestive disorder, and the prognosis of CAG is determined by many sociodemographic and clinicopathologic ...
About The Study: In an average-risk colorectal cancer screening population, a blood-based test demonstrated acceptable accuracy for colorectal cancer detection, but detection of advanced precancerous ...
Beta-CORRECT study to be presented at ASCO 2025 confirms the clinical utility of the molecular residual disease (MRD) test, Oncodetect™, for recurrence monitoring in stage II–IV colorectal cancer ...
The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England Journal ...
Serial CTRS (CT Response Score) improves prediction of overall survival compared to RECIST 1.1 and Tumor Volume Change in advanced NSCLC CHICAGO--(BUSINESS WIRE)--Onc.AI, a digital health company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results